RC
PRVA icon

Renaissance Capital’s Privia Health PRVA Stock Holding History

Renaissance Capital’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-71,299
Closed -$1.64M – 59
2023
Q4 		$1.64M Buy
71,299
+15,943
+29% +$357K 0.81% 36
2023
Q3 		$1.27M Buy
55,356
+29,038
+110% +$738K 0.68% 39
2023
Q2 		$687K Buy
26,318
+9,321
+55% +$246K 0.39% 52
2023
Q1 		$469K Buy
16,997
+410
+2% +$10.8K 0.35% 67
2022
Q4 		$377K Sell
16,587
-195
-1% -$5.43K 0.29% 71
2022
Q3 		$572K Buy
+16,782
New +$621K 0.37% 63

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Capital's PRVA Position: Q1 2024 in Review

Renaissance Capital sold out of Privia Health (PRVA) in Q1 2024, closing a stake of 71,299 shares — an estimated $1.64M sold.

Renaissance Capital first reported a position in PRVA in Q3 2022 and held it in 6 quarters. The position peaked at $1.64M in Q4 2023. 234 funds tracked by Wall St. Rank hold PRVA as of Q1 2024.

  • Renaissance Capital reported no remaining Privia Health position as of Q1 2024 after selling out during the quarter.
  • Renaissance Capital sold 71,299 Privia Health shares in Q1 2024, an estimated $1.64M.
  • Renaissance Capital first reported a position in Privia Health in Q3 2022 and held it in 6 quarters.
  • Renaissance Capital's Privia Health position peaked at $1.64M in Q4 2023.
  • 234 funds tracked by Wall St. Rank held Privia Health as of Q1 2024.

Based on Renaissance Capital's 13F filing for Q1 2024, filed 9 Apr 2024.